Baxter International | BAX - Stock


Baxter International reported $2.26B in Stock for its fiscal quarter ending in June of 2026.





Stock Change Date
Abbott USD 6.99B 501M Mar/2026
AngioDynamics USD 65.57M 3.56M Sep/2025
Artivion USD 103.36M 5.37M Jun/2026
AtriCure USD 83.92M 2.78M Jun/2026
Baxter International USD 2.26B 57M Jun/2026
Becton, Dickinson and Co. USD 3.32B 41M Jun/2026
Boston Scientific USD 3.24B 118M Jun/2026
Cooper Companies USD 896.4M 20M Mar/2026
Dexcom USD 726.4M 32.8M Jun/2026
Edwards Lifesciences USD 1.13B 12.2M Jun/2026
Fresenius EUR 2.73B 119M Mar/2026
Globus Medical USD 810.9M 38.3M Jun/2026
Halozyme Therapeutics USD 137.14M 18.33M Jun/2026
ICU Medical USD 607.42M 1.83M Jun/2026
Inogen USD 25.08M 762K Sep/2025
Insulet USD 484.8M 22.3M Jun/2026
Integra LifeSciences USD 492M 3.03M Jun/2026
Intuitive Surgical USD 2.03B 83.6M Jun/2026
J&J USD 15.14B 561M Jun/2026
Laboratory Of America USD 562.2M 64.5M Jun/2026
Medtronic USD 6.22B 264M Jun/2026
Merit Medical Systems USD 374.11M 21.73M Jun/2026
Quest Diagnostics USD 233M 8M Jun/2026
Stryker USD 5.52B 102M Jun/2026
Tandem Diabetes Care USD 135.11M 8.71M Jun/2026
Teleflex USD 351.91M 28.95M Jun/2026
Terumo JPY 335.63B 23.72B Mar/2026
Zimmer Biomet Holdings USD 2.27B 23.5M Jun/2026